VACCINE SATELLITE V - TOP-10 FACTS
VACCINE SATELLITE V - TOP-10 FACTS

Video: VACCINE SATELLITE V - TOP-10 FACTS

Video: VACCINE SATELLITE V - TOP-10 FACTS
Video: NoCap - Vaccine [Official Music Video] 2024, March
Anonim

Miracle drug … Russian vaccine against coronavirus "Sputnik V" … (Sputnik Ve) What's wrong with it? Let's take just 10 minutes to figure this out completely on real facts, and not on speculation and rumors. Let's start with the alarm bells and end with the most lethal facts.

So. First. The vaccine has passed the registration procedure for drugs used only in emergencies. In this case, vaccination sites should be equipped with anti-shock therapy.

Second. The sensitivity of the drug itself to storage conditions is very high: it turned out that it should be stored frozen, at a temperature not exceeding minus 18 degrees, before using it at room temperature, "but not longer than 30 minutes." Shaking the ampoule sharply is not allowed, as well as re-freezing. It is not surprising that the center is working so actively to register a dry version of Sputnik.

Third. Immunological properties and safety were studied only on adult healthy volunteers in the amount of 38 people for 42 days, therefore, the protective properties have not been fully investigated. “The protective titer is currently unknown, as is the duration of the protection. Clinical studies to study the epidemiological effectiveness have not been conducted, - this is a quote from the report of the Center. Gamalea, in which the vaccine was developed.

It is noted that on the 42nd day from the moment of vaccination, virus-neutralizing antibodies to the virus with an average titer of 49.3 were detected in the blood serum of all volunteers. Moreover, it should be borne in mind that the titer is the limiting dilution of blood serum at which antibodies, and the indicator at 49.3 is less than the average level of antibodies, and over time it may decrease even more.

The fourth, and one of the most important, is safety performance. In 38 subjects, 144 adverse events were recorded. Most passed without consequences. However, on the 42nd day of the study, 31 adverse events were not completed (laboratory deviations of immunological parameters were registered).

The developer still does not know the outcome of 27 undesirable phenomena, it follows from the documents. In volunteers after vaccination, swelling, pain, hyperthermia and itching at the injection site were recorded, and among the general manifestations - asthenia, malaise, pyrexia, fever, decreased appetite, headache, diarrhea, pain in the oropharynx, nasal congestion, sore throat, rhinorrhea.

Center documents. Gamaleas, formed on the basis of an open clinical study of safety, do not support the thesis of the absence of side effects, as many experts have assured.

Fifth. The developers have not published the details of the vaccine trial in any scientific journal, and until the full third phase studies are completed, the question of whether the vaccine is effective or not remains open. The point is that drug trials regularly fail at this stage.

So, in the current, third stage of vaccine trials, those who will be vaccinated do so actually at their own peril and risk. They are not obliged to sign the relevant papers, keep a volunteer's diary, they are not protected by the Declaration of Helsinki, and the manufacturer is not obliged to monitor the condition of people and include data on them in the study.

Sixth. Reaction from other countries The international community has reacted quite emotionally to the registration of the vaccine. The main complaint was that Russia has shortened the stages of vaccine testing, which, according to several countries, may have an impact on safety.

It is noted that such companies as Moderna, Pfizer / BioNTech, Oxford University / AstraZeneca, Sinopharm / Wuhan Institute of Biologicals, Chinese Sinovac, CanSinoBio, have started the third stage of testing, which is just beginning in Russia.

An important difference between Russia is also that most foreign manufacturers have published at least some test results in scientific journals, while there are still no details about the Russian vaccine in the literature. For example, a portrait of Putin in a James Bond suit with a syringe in his hands instead of a pistol was placed on the cover of the French magazine Libération. Headline: COVID Vaccine. Tomorrow never dies."

Recommended: